What is the main business of Bredent Group Polska?

The main business activity of Bredent Group Polska focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 13, 2024.

Where is the headquarters located?

The headquarters is located at: Aleje Ujazdowskie 41, 00-540 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from March 7, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company's revenue reached $92.

Is the company profitable?

No, in 2024 the company was not profitable, reporting a net loss of $113.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $205 in 2024, representing 100% of all operating expenses.

Bredent Group Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2024-03-13

Share capital

5,000.00 PLN

Registered address

Aleje Ujazdowskie 41, 00-540 Warszawa, Poland

Electronic delivery address

AE:PL-45302-53345-BIFGU-29

Financials

Revenue history

Filing timeliness

The financial statement for 2024 was filed on time.

2025filed
202412/05/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 1.07kMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD -6.88kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 7.60kMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 7.35kMedianUSD 609.79kAverageUSD 11.85m

Industry

Authorized Representatives

Florian Obǎdan – President of the Management Board

Manner of representation

Where the management board consists of more than one member, the President of the Management Board acting independently, or two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy or an attorney-in-fact, is authorised to make declarations of will and sign on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Bredent Medical Gmbh & Co. Kg	100	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2024-03-20.

Erste Bank Polska
53 1090 2574 0000 0001 5760 9806

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Black & Whitesp. z o.o.	$154,866.36	polonus.pl
Osteoprofsp. z o.o.	$72,065.80	osteoprof.pl
THC PharmaS.A.	$39,093.70	thc-pharma.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
Filicosp. z o.o.	$11,710.75	filico.eu
Get Ready Wheelchairssp. z o.o.	$9,842.54	getreadywheelchairs.com
Jacek Waksmundzki Trust 2S.K.A.	$5,769.53	trust.pl
Optimedussp. z o.o.	$1.00	optimedus.pl

Change history

Date	Event
2026-07-01	Business suspended
2025-01-29	Name change (Pianosa → Bredent Group Polska)
2025-01-29	PKD change (Removed: 9 codes; Added: 9 codes)
2024-03-13	Entered in the register

FAQ

Last updated: 2026-10-07